Silencing of Survivin Using YM155 Inhibits Invasion and Suppresses Proliferation in Glioma Cells

详细信息    查看全文

• 作者：Hua Guo (1)
  Yuexun Wang (2)
  Tao Song (1)
  Tao Xin (1)
  Zhiming Zheng (1)
  Peng Zhong (1)
  Xiaoli Zhang (3)
  
  1. Department of Neurosurgery ; Provincial Hospital Affiliated to Shandong University ; Jinan ; 250021 ; People鈥檚 Republic of China
  2. Department of CT ; First People鈥檚 Hospital ; Jining ; 272000 ; Shandong ; People鈥檚 Republic of China
  3. Department of Endocrinology ; Qilu Hospital ; Shandong University ; Jinan ; 250012 ; People鈥檚 Republic of China
  
• 关键词：GBM ; YM155 ; Survivin ; Invasion ; Migration
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：71
• 期：2
• 页码：587-593
• 全文大小：1,008 KB
• 参考文献：1. Surawicz, T. S., et al. (1998). Brain tumor survival: results from the National Cancer Data Base. / Journal of Neuro-oncology, / 40(2), 151鈥?60. CrossRef
  2. Grossman, S. A., & Batara, J. F. (2004). Current management of glioblastoma multiforme. / Seminars in Oncology, / 31(5), 635鈥?44. CrossRef
  3. Quick, A., et al. (2010). Current therapeutic paradigms in glioblastoma. / Reviews on Recent Clinical Trials, / 5(1), 14鈥?7. CrossRef
  4. Ambrosini, G., Adida, C., & Altieri, D. C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. / Nature Medicine, / 3(8), 917鈥?21. CrossRef
  5. Chakravarti, A., et al. (2002). Quantitatively determined survivin expression levels are of prognostic value in human gliomas. / Journal of Clinical Oncology, / 20(4), 1063鈥?068. CrossRef
  6. Kajiwara, Y., et al. (2003). Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. / Cancer, / 97(4), 1077鈥?083. CrossRef
  7. Saito, T., et al. (2007). Survivin subcellular localization in high-grade astrocytomas: Simultaneous expression in both nucleus and cytoplasm is negative prognostic marker. / Journal of Neuro-oncology, / 82(2), 193鈥?98. CrossRef
  8. George, J., Banik, N. L., & Ray, S. K. (2010). Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. / Neuro-Oncology, / 12(11), 1088鈥?101. CrossRef
  9. Kang, D. W., et al. (2008). Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells. / Neurochemical Research, / 33(3), 551鈥?61. CrossRef
  10. Kardosh, A., et al. (2007). Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. / Journal of Biomedical Science, / 14(5), 647鈥?62. CrossRef
  11. Blum, R., et al. (2006). Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis. / Molecular Cancer Therapeutics, / 5(9), 2337鈥?347. CrossRef
  12. Schultze, K., et al. (2006). Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. / Apoptosis, / 11(9), 1503鈥?512. CrossRef
  13. Nakahara, T., et al. (2007). YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. / Cancer Research, / 67(17), 8014鈥?021. CrossRef
  14. Wang, Q., et al. (2011). Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells. / Cancer Letters, / 302(1), 29鈥?6. CrossRef
  15. Nakahara, T., et al. (2011). YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model. / Anti-Cancer Drugs, / 22(5), 454鈥?62. CrossRef
  16. Iwasa, T., et al. (2008). Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines. / Clinical Cancer Research, / 14(20), 6496鈥?504. CrossRef
  17. Zhang, Y., et al. (2009). siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells. / Pathology, Research and Practice, / 205(12), 823鈥?27. CrossRef
  18. Lai, P. C., et al. (2012). Novel survivin inhibitor YM155 elicits cytotoxicity in glioblastoma cell lines with normal or deficiency DNA-dependent protein kinase activity. / Pediatrics and Neonatology, / 53(3), 199鈥?04. CrossRef
  19. Qin, F. X., et al. (2011). Knockdown of NPM1 by RNA interference inhibits cells proliferation and induces apoptosis in leukemic cell line. / International Journal of Medical Sciences, / 8(4), 287鈥?94. CrossRef
  20. Liao, W., et al. (2013). Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells. / PLoS ONE, / 8(12), e80789. CrossRef
  21. Walter, M. N., et al. (2010). Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. / Experimental Cell Research, / 316(7), 1271鈥?281. CrossRef
  22. Lin, G. S., et al. (2014). STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma. / International Journal of Clinical and Experimental Pathology, / 7(6), 3141鈥?149.
  23. Ostrom, Q. T., et al. (2013). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. / Neuro-Oncology, 15(Suppl 2), ii1鈥?6.
  24. Stupp, R., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. / New England Journal of Medicine, / 352(10), 987鈥?96. CrossRef
  25. Velculescu, V. E., et al. (1999). Analysis of human transcriptomes. / Nature Genetics, / 23(4), 387鈥?88. CrossRef
  26. O鈥機onnor, D. S., et al. (2000). Control of apoptosis during angiogenesis by survivin expression in endothelial cells. / American Journal of Pathology, / 156(2), 393鈥?98. CrossRef
  27. Shin, S., et al. (2001). An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. / Biochemistry, / 40(4), 1117鈥?123. CrossRef
  28. Liu, T., Brouha, B., & Grossman, D. (2004). Rapid induction of mitochondrial events and caspase-independent apoptosis in survivin-targeted melanoma cells. / Oncogene, / 23(1), 39鈥?8. CrossRef
  29. Li, F., et al. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. / Nature, / 396(6711), 580鈥?84. CrossRef
  30. Mirza, A., et al. (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. / Oncogene, / 21(17), 2613鈥?622. CrossRef
  31. Hoffman, W. H., et al. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. / Journal of Biological Chemistry, / 277(5), 3247鈥?257. CrossRef
  32. Pennati, M., Folini, M., & Zaffaroni, N. (2008). Targeting survivin in cancer therapy. / Expert Opinion on Therapeutic Targets, / 12(4), 463鈥?76. CrossRef
  33. Or, Y. Y., et al. (2014). Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma. / Molecular Medicine Reports. doi:10.3892/mmr.2014.2413 .
  34. Dohi, T., Xia, F., & Altieri, D. C. (2007). Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. / Molecular Cell, / 27(1), 17鈥?8. CrossRef
  35. Mehrotra, S., et al. (2010). IAP regulation of metastasis. / Cancer Cell, / 17(1), 53鈥?4. CrossRef
  
• 刊物主题：Biochemistry, general; Pharmacology/Toxicology; Biotechnology; Cell Biology; Biophysics and Biological Physics;
• 出版者：Springer US
• ISSN：1559-0283

文摘

Survivin has multiple functions in the progression of cancer. The aim of the present study was to investigate the influence of YM155, a specific survivin inhibitor, on the biological behavior of U87 glioblastoma cells. The proliferative activity and growth rate of U87 cells were determined by colony formation assay and mononuclear cell direct cytotoxicity assay (MTT assay). The reconstituted basement membrane penetrating capacity was determined by cell invasion assay. The cell movement and migratory capacity were detected by wound-healing repair assay. We found that inhibition of survivin by YM155 dramatically decreased the invasive and metastatic capacities of the cells, suppressed the proliferation, decelerated the rate of growth, and reduced the number of clones on soft agar. In conclusion, YM155 has the potential to be used in the clinical treatment of GBM.